MAPS Act

HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile

Client expense: Not reported · Firm income: $80,000

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 405 - Essential Medicines Strategic Stockpile Act of 2023 HR 3837 - Improving Public Health Preparedness Act HR 3557 - Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act S.2333/HR 4421 - Pandemic and All-Hazards Preparedness and Response Act HR 4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile

Client expense: $511,136 · Firm income: Not reported

Reproductive health, physician-patient relationship, and EMTALA issues Emergency department boarding Drug shortages Health care consolidation H.R.1694-Emergency Care Improvement Act, to permanently allow for coverage under Medicare and Medicaid of services that are provided by freestanding emergency centers. H.R.2412-Helping Kids Cope Act, to provide grants to improve mental health access for children and reduce pediatric emergency department boarding H.R. 2416-To reauthorize the MISSION ZERO military-civilian partnership for trauma readiness H.R. 2940-PASTEUR Act of 2023, to incentivize new antimicrobial development H.R.4941-Providing Access to Treatment and Housing Act H.R 5414-Improving Mental Health Access from the Emergency Department Act, to establish grants for emergency departments and hospitals to help improve care and care coordination for patients with acute psychiatric care needs H.R.5804-Mental Health Infrastructure Improvement Act of 2023, to provide loans and grants to improve mental health treatment and substance use disorder treatment facilities H.R.6960-Emergency Medical Services for Children Reauthorization Act of 2024, to reauthorize the EMSC program H.R. 6992-Mapping Americas Pharmaceutical Supply Act, to map the U.S. pharmaceutical supply chain to identify vulnerabilities and other security threats H.R. 7153-Dr. Lorna Breen Health Care Provider Protection Act, to reauthorize programs to improve mental health access for health care providers S. 1346-Improving Mental Health Access from the Emergency Department Act, to establish grants for emergency departments and hospitals to help improve care and care coordination for patients with acute psychiatric care needs S. 1355- PASTEUR Act of 2023, to incentivize new antimicrobial development S. 1447-Bipartisan Solution to Cyclical Violence Act of 2023, to establish a grant program to support trauma center violence intervention and violence prevention programs S. 2586-Drug Shortages Prevention and Quality Improvement Act S. 2364-Mapping Americas Pharmaceutical Supply Act, to map the U.S. pharmaceutical supply chain to identify vulnerabilities and other security threats S.3679-Dr. Lorna Breen Health Care Provider Protection Act, to reauthorize programs to improve mental health access for health care providers S.3765-Emergency Medical Services for Children Reauthorization Act of 2024, to reauthorize the EMSC program

H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 8333 - BIOSECURE Act: Provisions related to pharmaceutical supply chain and drug shortages.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 652/HR 2630: Safe Step Act- implementing safe guards around step therapy (fail first) programs in ERISA regulated plan S 1375/HR 830: HELP Copays Act- copay accumulator programs Addressing Pharmacy Benefit Managers S 127: Pharmacy Benefit Manager Transparency Act of 2023- prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S 79: Interagency Patent Coordination and Improvement Act of 2023- establishes an interagency taskforce between the United States Patent and Trademark Office and the FDA S 2243: Palliative Care and Hospice Education and Training Act (PCHETA)- promote education and research in palliative care and hospice Palliative care S 2213: Comprehensive Cancer Survivorship Act- cancer survivorship S 2039: Cancer Drug Parity Act of 2023- oral parity for cancer drugs HR 3633: PREVENT HPV Cancers Act of 2023 S 1624/HR 3391: Gabriella Miller Kids First Research Act 2.0- pediatric cancer research Addressing healthcare workforce shortages Increasing diversity in clinical trials Mitigating drug shortages and increasing supply chain resiliency and future pandemic preparedness, including bolstering the strategic national stockpile S 1961: Pharmaceutical Supply Chain Risk Assessment Act of 2023- require an interagency risk assessment of the pharmaceutical supply chain to identify and mitigate health and national security risks HR 3810: Drug Origin Transparency Act of 2023 - Require drug manufacturers to report to the Food and Drug Administration (FDA) quarterly the supplier's location and drug ingredients HR 3793: Ensuring Access to Lifesaving Drugs Act of 2023 - require manufacturers of life-saving drugs to submit data and information to assess the stability of the drugs and determine their longest supported expiration date, and for other purposes. S 2364: MAPS ACT - A bill to map the United States pharmaceutical supply chain S 2510: RAPID Reserve Act - establish reserves of both Active Pharmaceutical Ingredients (APIs) and finished drug products to be held as vendor-managed inventory and used when needed to prevent supply disruptions HR 5526: Seniors' Access to Critical Medications Act of 2023 - make permanent a waiver issued by the Centers for Medicare and Medicaid Services (CMS) that allowed for Medicare patients to receive critical medications by mail or allow for caregivers and family members to obtain medications for them. HR 6301: Cancer Drug Parity Act of 2023 - To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. HR 6963: To direct the Secretary of Health and Human Services to enter into agreements with drug manufacturers to establish reserve supplies of covered pediatric cancer drugs, and for other purposes - establish reserve supplies of covered pediatric cancer drugs, and for other purposes. HR 6992: Mapping America's Pharmaceutical Supply Act- require the Department of Health and Human Services to update its essential medicines list and create a database to help predict vulnerabilities in the U.S. pharmaceutical supply chain. S 3458: Seniors' Access to Critical Medications Act of 2023 - clarify the application of the in-office ancillary services exception to the physician self-referral prohibition for drugs furnished under the Medicare program. HR 8404/S 4330: ROCR Value Based Program Act of 2024 - To amend title XVIII of the Social Security Act to create a Radiation Oncology Case Rate Value Based Payment Program exempt from budget neutrality adjustment requirements, and to amend section 1128A of title XI of the Social Security Act to create a new statutory exception for the provision of free or discounted transportation for radiation oncology patients to receive radiation therapy services.

HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile

Client expense: Not reported · Firm income: $80,000

PAHPA reauthorization, including S.2333 - the Pandemic and All-Hazards Preparedness and Response Act and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act; Pharmaceutical supply chain issues; H.R.6992/S.2364 - MAPS Act; H.R.3008/S.2363 - Drug Shortage Prevention and Mitigation Act; S.5040 -Protecting Patients from Deceptive Drug Ads Online Act; Issues related to drug shortages.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 405 - Essential Medicines Strategic Stockpile Act of 2023 HR 3837 - Improving Public Health Preparedness Act HR 3557 - Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act S.2333/HR 4421 - Pandemic and All-Hazards Preparedness and Response Act HR 4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile

Client expense: $497,548 · Firm income: Not reported

Medicare and Medicaid payment issues Health care workforce Drug Shortages Health Equity / Social determinants of health Maternal Health Behavioral and Mental Health MACRA reform Hospital consolidation Health care pricing transparency Tax Exempt Hospitals Primary Care and Health Workforce Expansion Act Lower Cost More Transparency Act Site Neutral 340B Drug Pricing MA prior authorization Medicare hospital wage index Telehealth and digital health Home health Rural health Pediatric drug shortages and the Pediatric Cancer Drug Supply Act of 2024 (H.R. 6963) COMPLETE Care Act (H.R. 5819) Artificial intelligence Lorna Breen Health Care Worker Safety Reauthorization Act (S. 3679 / H.R. 7153) and appropriations to same SAVE Act (S. 2768 / H.R. 2584) Lab developed tests Mobile stroke unit funding Connected MOM (S. 712) 340B Patients Act (H.R. 7635 / S. 3922) Improving Seniors' Timely Access to Care Act (H.R. 9702 / S. 4532) Connect Act (H.R. 4189 /S. 2016) MAPS Act (H.R. 6992) H. Res. 389 - In support of Healthcare workers TEAM Model implementation Physician Fee Schedule Medical Graduate Investment Act

Client expense: Not reported · Firm income: $60,000

Medicare and Medicaid payment issues Health care workforce Drug Shortages Health Equity / Social determinants of health Maternal Health Behavioral and Mental Health MACRA reform Hospital consolidation Health care pricing transparency Tax Exempt Hospitals Primary Care and Health Workforce Expansion Act Lower Cost More Transparency Act Site Neutral 340B Drug Pricing MA prior authorization Medicare hospital wage index Telehealth and digital health Home health, rural health Pediatric drug shortages and the Pediatric Cancer Drug Supply Act of 2024 (H.R. 6963) Centers for Medicare & Medicaid Services (CMS) direct contracting and the Global and Professional Direct Contracting (GPDC) Program MEDICAID Provider Assessment Program and prescription payment issues COMPLETE Care Act (H.R. 5819) Artificial intelligence Lorna Breen Health Care Worker Safety Reauthorization Act (S. 3679 / H.R. 7153) SAVE Act (S. 2768 / H.R. 2584) Lab developed tests Mobile stroke unit funding Connected MOM (S. 712) 340B Patients Act (H.R. 7635 / S. 3922) Improving Seniors' Timely Access to Care Act (H.R. 9702 / S. 4532) Connect Act (H.R. 4189 /S. 2016) MAPS Act (H.R. 6992)

Client expense: Not reported · Firm income: $60,000

S 652/HR 2630: Safe Step Act- implementing safe guards around step therapy (fail first) programs in ERISA regulated plan S 1375/HR 830: HELP Copays Act- copay accumulator programs Addressing Pharmacy Benefit Managers S 127: Pharmacy Benefit Manager Transparency Act of 2023- prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S 79: Interagency Patent Coordination and Improvement Act of 2023- establishes an interagency taskforce between the United States Patent and Trademark Office and the FDA S 2243: Palliative Care and Hospice Education and Training Act (PCHETA)- promote education and research in palliative care and hospice Palliative care S 2213: Comprehensive Cancer Survivorship Act- cancer survivorship S 2039: Cancer Drug Parity Act of 2023- oral parity for cancer drugs HR 3633: PREVENT HPV Cancers Act of 2023 S 1624/HR 3391: Gabriella Miller Kids First Research Act 2.0- pediatric cancer research Addressing healthcare workforce shortages Increasing diversity in clinical trials Mitigating drug shortages and increasing supply chain resiliency and future pandemic preparedness, including bolstering the strategic national stockpile S 1961: Pharmaceutical Supply Chain Risk Assessment Act of 2023- require an interagency risk assessment of the pharmaceutical supply chain to identify and mitigate health and national security risks HR 3810: Drug Origin Transparency Act of 2023 - Require drug manufacturers to report to the Food and Drug Administration (FDA) quarterly the supplier's location and drug ingredients HR 3793: Ensuring Access to Lifesaving Drugs Act of 2023 - require manufacturers of life-saving drugs to submit data and information to assess the stability of the drugs and determine their longest supported expiration date, and for other purposes. S 2364: MAPS ACT - A bill to map the United States pharmaceutical supply chain S 2510: RAPID Reserve Act - establish reserves of both Active Pharmaceutical Ingredients (APIs) and finished drug products to be held as vendor-managed inventory and used when needed to prevent supply disruptions HR 5526: Seniors' Access to Critical Medications Act of 2023 - make permanent a waiver issued by the Centers for Medicare and Medicaid Services (CMS) that allowed for Medicare patients to receive critical medications by mail or allow for caregivers and family members to obtain medications for them. HR 6301: Cancer Drug Parity Act of 2023 - To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. HR 6963: To direct the Secretary of Health and Human Services to enter into agreements with drug manufacturers to establish reserve supplies of covered pediatric cancer drugs, and for other purposes - establish reserve supplies of covered pediatric cancer drugs, and for other purposes. HR 6992: Mapping America's Pharmaceutical Supply Act- require the Department of Health and Human Services to update its essential medicines list and create a database to help predict vulnerabilities in the U.S. pharmaceutical supply chain. S 3458 Seniors' Access to Critical Medications Act of 2023 - clarify the application of the in-office ancillary services exception to the physician self-referral prohibition for drugs furnished under the Medicare program.

H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment and supply chain shortages. National Defense Authorization Act; Labor, Health and Human Services and related agencies Appropriations: Provisions related to pharmaceutical supply chain and quality. Issues related to drug shortages.

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reproductive health, physician-patient relationship, and EMTALA issues Emergency department boarding Drug shortages Health care consolidation H.R.1694-Emergency Care Improvement Act, to permanently allow for coverage under Medicare and Medicaid of services that are provided by freestanding emergency centers. H.R.2412-Helping Kids Cope Act, to provide grants to improve mental health access for children and reduce pediatric emergency department boarding H.R. 2416-To reauthorize the MISSION ZERO military-civilian partnership for trauma readiness H.R. 2940-PASTEUR Act of 2023, to incentivize new antimicrobial development H.R.4941-Providing Access to Treatment and Housing Act H.R 5414-Improving Mental Health Access from the Emergency Department Act, to establish grants for emergency departments and hospitals to help improve care and care coordination for patients with acute psychiatric care needs H.R.5804-Mental Health Infrastructure Improvement Act of 2023, to provide loans and grants to improve mental health treatment and substance use disorder treatment facilities H.R.6960-Emergency Medical Services for Children Reauthorization Act of 2024, to reauthorize the EMSC program H.R. 6992-Mapping Americas Pharmaceutical Supply Act, to map the U.S. pharmaceutical supply chain to identify vulnerabilities and other security threats H.R. 7153-Dr. Lorna Breen Health Care Provider Protection Act, to reauthorize programs to improve mental health access for health care providers S. 1346-Improving Mental Health Access from the Emergency Department Act, to establish grants for emergency departments and hospitals to help improve care and care coordination for patients with acute psychiatric care needs S. 1355- PASTEUR Act of 2023, to incentivize new antimicrobial development S. 1447-Bipartisan Solution to Cyclical Violence Act of 2023, to establish a grant program to support trauma center violence intervention and violence prevention programs S. 2586-Drug Shortages Prevention and Quality Improvement Act S. 2364-Mapping Americas Pharmaceutical Supply Act, to map the U.S. pharmaceutical supply chain to identify vulnerabilities and other security threats S.3679-Dr. Lorna Breen Health Care Provider Protection Act, to reauthorize programs to improve mental health access for health care providers S.3765-Emergency Medical Services for Children Reauthorization Act of 2024, to reauthorize the EMSC program

HR 405 - Essential Medicines Strategic Stockpile Act of 2023 HR 3837 - Improving Public Health Preparedness Act HR 3557 - Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act S.2333/HR 4421 - Pandemic and All-Hazards Preparedness and Response Act HR 4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile

Client expense: $518,503 · Firm income: Not reported

340B Drug Pricing Program - Continued to urge action to ensure covered entities have access to 340B discounted prices through contract pharmacies. Highlighted critical importance of the 340B program for hospitals. Responded to the discussion draft of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act) and supplemental request for information (RFI). Buffer inventory - Engagements with CMS on reimbursement for hospitals that stockpile buffer supplies of essential medicines. Children's Hospital Graduate Medical Education (CHGME) - Continued to urge Congress to reauthorize CHGME program through the Childrens Hospital GME Support Reauthorization Act of 2023 (H.R. 3887). Offered support for providing $738 million in funding the CHGME program. Drug shortages -Supported elements to increase transparency in prescription drug supply chain and increase reimbursement for generic prescription drugs; issues related to compounding; issues related to buffer inventory. Engaged on recent FTC/HHS joint Request for Information related to generic drug shortages, as well as the January Senate Finance Committee White Paper Preventing and Mitigating Generic Drug Shortages: Policy Options Under Federal Health Programs. Continued supporting passage of The Drug Shortage Prevention Act (H.R. 3008) and The Drug Origin Transparency Act (H.R. 3810) and engaged on the Stop Drug Shortages Act (McMorris Rodgers, No Bill Number) discussion draft. Endorsed passage of legislation to address patent thickets (H.R. 6986/S.3583). Endorsed passage of the Affordable Prescriptions for Patients Act (S.150). Endorsed passage of the Mapping Americas Pharmaceutical Supply (MAPS) Act (H.R. 6992). Healthcare Workforce - Endorsed passage of the Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S. 2768). Monitored development of the Bipartisan Primary Care and Health Workforce Act (S.2840). Hospital Group Purchasing - Advocated to highlight the value that hospital group purchasing organizations provide to hospitals and suppliers. Provided education on how GPOs work in the healthcare supply chain and the role they play in delivering value to healthcare providers, as well as key differences between traditional GPOs and PBMs. Medical Device Sterilization - Conducted education and outreach on the potential negative impact on the healthcare supply chain of pending regulations limiting the use of Ethylene Oxide as a medical device sterilant. Mental and Behavioral Health - Highlighted the need for legislation to address significant challenges to mental and behavioral health treatment, including increased demand for services, limited access to treatment, and clinician shortages. Payer-mandated White Bagging - Urged support for policy updates related to payer-mandated white bagging for medications. Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421) and Preparedness and Response Reauthorization Act (H.R. 4420) - Supported timely passage of legislation to reauthorize the Pandemic and All Hazards Preparedness Act. Advocated for including provisions to increase transparency in the healthcare supply chain and improve hospital and health system emergency preparedness. Social Determinants of Health - Encouraged Congress and agencies to ensure tools like the Vizient Vulnerability Index are being utilized to understand and identify social drivers of health at the neighborhood level. Supported an increase in the Physician Fee Schedule conversion factor in Consolidated Appropriations Act, 2024 (H.R. 4366) to offset recent administrative payment cuts. Telehealth - Continued supporting passage of the CONNECT for Health Act (S. 2016/H.R. 4189). Continued to advocate for the adoption of permanent telehealth policies to extend flexibilities beyond the current 2024 expiration date.

H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment and supply chain shortages.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to drug pricing, drug shortages, drug importation plans, and the drug supply chain, including support for the following bills: Mapping Americas Pharmaceutical Supply (MAPS) Act (H.R. 6992), and the Pediatric Cancer Drug Supply Act of 2024 (H.R. 6963). Issues related to COVID-19 response and post-public health emergency recommendations, including telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Issues related to combatting opioid addiction, including support for the following bills: the Fentanyl Safe Testing and Overdose Prevention Act (S. 2569) and the Test Strip Access Act of 2023 (H.R. 4106). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Reauthorization of the Pandemic and All-Hazards Preparedness Act, including recommendations to leverage pharmacists as part of the care team. Patient access to comprehensive reproductive healthcare (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). The Lower Costs, More Transparency Act (H.R. 5378) and the Site-based Invoicing and Transparency Enhancement (SITE) Act (S. 1869), provisions related to site neutral payments. The Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153/S. 3679), provisions related to supporting health workers mental health and well-being. Issues related to the Change Healthcare cyberattack, including communications with the Department of Health and Human Services and the Centers for Medicare & Medicaid Services encouraging flexibility following the cyberattack (generally, no specific legislation).